These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7576325)
1. Effects of aerosolized pentamidine on glucose homeostasis and insulin secretion in HIV-positive patients: a controlled study. Uzzan B; Bentata M; Campos J; Mosnier A; Krivitzky A; Perret GY; Modigliani E AIDS; 1995 Aug; 9(8):901-7. PubMed ID: 7576325 [TBL] [Abstract][Full Text] [Related]
2. Safety of pentamidine prophylaxis for Pneumocystis carinii pneumonia on the endocrine pancreatic function in HIV patients. Veyssier P; Cevallos R; Le Fouillé-Ribeyre C; Geffray L; Kaloustian E; Farinotti R Ann Med Interne (Paris); 1994; 145(7):464-6. PubMed ID: 7864513 [TBL] [Abstract][Full Text] [Related]
3. Lack of desensitization to aerosol pentamidine with long-term use. Rawji A; Lee-Pack LR; Favell K; Chan CK J Aerosol Med; 1996; 9(2):241-8. PubMed ID: 10163353 [TBL] [Abstract][Full Text] [Related]
4. Aerosolized pentamidine prophylaxis against AIDS-related Pneumocystis carinii pneumonia and its short- and long-term effects on pulmonary function in the Japanese. Konishi M; Yoshimoto E; Takahashi K; Uno K; Kasahara K; Murakawa K; Maeda K; Mikasa K; Narita N J Infect Chemother; 2003 Jun; 9(2):178-82. PubMed ID: 12825119 [TBL] [Abstract][Full Text] [Related]
5. [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations]. Stoehr A; Plettenberg A; Albrecht H; Stellbrink HJ; Meigel W; Begemann F Med Klin (Munich); 1994 Mar; 89(3):132-5. PubMed ID: 8196573 [TBL] [Abstract][Full Text] [Related]
6. An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group. McIvor RA; Berger P; Pack LL; Rachlis A; Chan CK Chest; 1996 Jul; 110(1):141-6. PubMed ID: 8681618 [TBL] [Abstract][Full Text] [Related]
7. Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic human immunodeficiency virus infection. The Italian Pediatric Collaborative Study Group on Pentamidine. Principi N; Marchisio P; Onorato J; Gabiano C; Galli L; Caselli D; Morandi B; Campelli A; Clerici M; Gattinara GC J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):158-63. PubMed ID: 8680887 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144 [TBL] [Abstract][Full Text] [Related]
9. High dose aerosol pentamidine for secondary Pneumocystis carinii pneumonia prophylaxis in AIDS patients. Flamholc L; Haidl S; Westin E; Borgdalen L; Prellner T Infection; 1992; 20(6):309-12. PubMed ID: 1293048 [TBL] [Abstract][Full Text] [Related]
10. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145 [TBL] [Abstract][Full Text] [Related]